CALADRIUS BIOSCIENCES INC's ticker is CLBS and the CUSIP is 128058203. A total of 36 filers reported holding CALADRIUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | -30.8% | 17,730 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | -13.3% | 17,730 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $15,000 | -31.8% | 17,730 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $22,000 | -24.1% | 17,730 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $29,000 | -14.7% | 17,730 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $34,000 | +36.0% | 17,730 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $25,000 | -7.4% | 17,730 | 0.0% | 0.00% | -40.0% |
| Q3 2020 | $27,000 | -15.6% | 17,730 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $32,000 | 0.0% | 17,730 | 0.0% | 0.01% | -33.3% |
| Q1 2020 | $32,000 | -30.4% | 17,730 | 0.0% | 0.01% | -43.8% |
| Q3 2019 | $46,000 | -28.1% | 17,730 | 0.0% | 0.02% | -42.9% |
| Q1 2019 | $64,000 | -12.3% | 17,730 | 0.0% | 0.03% | +133.3% |
| Q1 2018 | $73,000 | -3.9% | 17,730 | 0.0% | 0.01% | +20.0% |
| Q4 2017 | $76,000 | – | 17,730 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 241,075 | $345,000 | 0.07% |
| Virtu Financial LLC | 52,599 | $75,000 | 0.01% |
| Summit Trail Advisors, LLC | 17,730 | $25,000 | 0.00% |
| Renaissance Technologies | 1,045,855 | $1,496,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 207,218 | $296,000 | 0.00% |
| TSFG, LLC | 1 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 342,608 | $490,000 | 0.00% |
| UBS Group AG | 6,490 | $9,000 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 300 | $0 | 0.00% |
| IFP Advisors, Inc | 80 | $0 | 0.00% |